✦ LIBER ✦

Timing of chemotherapy-induced neutropenia is a prognostic factor in patients with metastatic non-small-cell lung cancer: a retrospective analysis in gemcitabine-plus-platinum-treated patients

✍ Scribed by Seung Hun Jang, Seong Yeol Kim, Joo Hee Kim…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy-induced neutropenia as a pr

✍ Pallis, A.G.; Agelaki, S.; Kakolyris, S.; Kotsakis, A.; Kalykaki, A.; Vardakis, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Gemcitabine in Patients with Non–Small-C

✍ Primo N. Lara Jr; Paul H. Gumerlock; Philip C. Mack; Derick H.M. Lau; Regina Gan 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 327 KB

Prognostic factors for safety in non sma

✍ Bérille, J; Olivares, R; Hammershaimb, L; Kim, Y; Pham Tran, N; Lelann, L; Gamza 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

The T393C polymorphism ofGNAS1as a predi

✍ Xie, Fa-Jun; Zhao, Peng; Kou, Jun-Yan; Hong, Wei; Fu, Li; Hu, Lin; Hong, Dan; Su 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 311 KB

Advance lung cancer inflammation index (

✍ Syed H Jafri, Runhua Shi, Glenn Mills 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 255 KB

Efficacy of gemcitabine plus platinum ch

✍ Le Chevalier, T.; Scagliotti, G.; Natale, R.; Danson, S.; Rosell, R.; Stahel, R. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 313 KB